Search Results
Results found for "British Pharmacological Society"
- GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
Through genetic and pharmacologic modulations of GRK3, a series of functional and molecular studies were
- G protein-coupled receptor signaling: transducers and effectors
We will first summarize their prominent roles in GPCR pharmacology before transitioning into less well-explored
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Career opportunities: Snapshot of roles spanning PhD entry points to senior translational pharmacology—Protein Expression, Drug Discovery Scientist, and Staff Scientist in Molecular Pharmacology—curated with notes
- Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype
develop drugs with less side effects, and tools to explore the ORs nature and function, various (poly)pharmacological
- Targeting Intracellular Allosteric Sites in GPCRs
Recent advances in structural biology and pharmacology have revealed the existence of allosteric sites Allosteric modulators targeting GPCRs can display one or more of the following pharmacological characteristics their allosteric influence, an attribute that offers a considerable degree of adjustability in terms of pharmacological
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
the core mediator — demonstrating the reach of these signaling pathways beyond classical receptor pharmacology
- 📰 GPCR Weekly News, May 6 to 12, 2024
University We successfully started our Dr.GPCR University workshop, 'Advanced Data Analysis for GPCR Pharmacology 2024 | 9th GPCRs in Medicinal Chemistry July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs Post Doctoral Fellow Postdoc Position Principal Scientist, In vitro Pharmacology Senior
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
development and progress in optimising physicochemical properties, understanding advanced molecular pharmacology
- Michel Bouvier appointed Knight of the Ordre national du Québec
22, 2022, Michel Bouvier, Chief Executive Officer of IRIC, Principal Investigator of the Molecular Pharmacology
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
development and progress in optimizing physicochemical properties, understanding advanced molecular pharmacology
- G protein-coupled receptor 21 in macrophages: An in vitro study
analyzing (i) its involvement in cell migration and cytokine release and (ii) the consequence of its pharmacological
- Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
LINKED ARTICLES: This article is part of a themed issue on Structure Guided Pharmacology of Membrane
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
platform enables rapid generation of conjugates, such as labeled ligands, with excellent affinity and pharmacological
- Dr. GPCR University registration is now open! Secure your spot now!
Reading Materials Access to the private group Certificate Explore: Key metrics for assessing ligand pharmacology , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology
- Interacting binding insights and conformational consequences of the differential activity of...
major non-psychoactive phytocannabinoid present in the plant Cannabis sativa, has displayed beneficial pharmacological Our work will pave the way for understanding the CBD pharmacology at a molecular level and aid in harnessing
- 📰 GPCR Weekly News, June 19 to 25, 2023
Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology GPCRs, Ion Channels, and Transport Proteins (March 24 - 29, 2024) GPCR Jobs Professor in Cardiovascular Pharmacology
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
of GPR84 and, in the absence of direct structural information, recent developments and use of GPR84 pharmacological
- Label-free LC-MS based assay to characterize small molecule compound binding to cells
small molecule binding to live cells provides important information on the characterization of ligands pharmacologically
- From Snapshots to Predictions: Why Mechanism of Action Matters
By the end, you’ll know how to use pharmacological models to separate lookalikes, explain puzzling outcomes When Two Mechanisms Look the Same Some of the most difficult calls in pharmacology happen when two different
- 📰 GPCR Weekly News, December 4 to 10, 2023
This comprehensive course covers fundamental pharmacology in four weekly segments, delving into Agonists , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
Here, we review how nanobodies have been adopted to elucidate the structure, pharmacology, and signaling
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
underlying biased agonism at the GLP-1R are beginning to be elucidated through a combination of mutagenesis, pharmacological Biochemical Pharmacology, 2024. 222 : p. 116119. 5.
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
small-molecule-based fluorescent CCR2 ligand 14 represents a promising tool for future studies of CCR2 pharmacology
- From DNA day to GPCR genomics
The integration of genomics with structural biology, pharmacology, bioinformatics, and clinical research Molecular pharmacology, 63(6), 1256–1272. https://doi.org/10.1124/mol.63.6.1256 Syed Haneef, S.
- 📰 GPCR Weekly News, November 6 to November 12, 2023
9th GPCRs in Medicinal Chemistry NEW July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology Antibody Discovery Staff Scientist (AC-TAP) in Database Development at Department of Drug Design and Pharmacology
- 📰 GPCR Weekly News, June 5 to 11, 2023
Berchiche is at the Molecular Pharmacology GRC, if you are also on-site, please stop by and say hi. Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology
- A broad look into the future of systemic sclerosis
Pharmacological interventions, although for other indications, are already in clinical use to address
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
Knockout of PLCβ3, or pharmacological inhibition of its upstream regulators, Gβγ or Gq, ex vivo in periaqueductal
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
Over the past 2 decades, pepducins have progressed initially from pharmacologic tools used to manipulate
- 📰 GPCR Weekly News, August 28 to September 3, 2023
female common diseases: a guard of women's health β-Arrestins: Structure, Function, Physiology, and Pharmacological Postdoc Research Associate Director, Regulatory Affairs Research Scientist/Senior Scientist I - Molecular Pharmacology





